AHRAmerican Healthcare REIT, Inc.

OTC www.americanhealthcarereit.com


$ 24.36 $ -0.20 (-0.81 %)    

Monday, 16-Sep-2024 15:59:55 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 24.38
$ 24.35 x 100
-- x --
-- - --
$ 12.20 - $ 25.10
1,881,562
na
3.21B
$ 0.79
nm
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-22-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-17-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-25-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-26-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-19-2020 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-12-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-10-2018 06-30-2018 10-Q
26 05-11-2018 03-31-2018 10-Q
27 03-08-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-01-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-10-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 03-07-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Keybanc analyst Austin Wurschmidt maintains American Healthcares (NYSE:AHR) with a Overweight and raises the price target fr...

Core News & Articles

Truist Securities analyst Michael Lewis maintains American Healthcares (NYSE:AHR) with a Buy and raises the price target fro...

Core News & Articles

Morgan Stanley analyst Ronald Kamdem maintains American Healthcares (NYSE:AHR) with a Overweight and raises the price target...

Core News & Articles

B of A Securities analyst Joshua Dennerlein maintains American Healthcares (NYSE:AHR) with a Buy and raises the price target...

Core News & Articles

B of A Securities maintains American Healthcares (NYSE:AHR) with a Buy and raises the price target from $16 to $19.

Core News & Articles

JMP Securities analyst Aaron Hecht maintains American Healthcares (NYSE:AHR) with a Market Outperform and raises the price t...

 mortgage-rates-fall-to-15-month-lows-boost-homebuyer-demand-as-federal-reserve-hints-at-rate-cuts

Bond yields drop on expectations of Fed rate cut, leading to lowest mortgage rates in over a year and surge in mortgage applica...

Core News & Articles

American Healthcares (NYSE:AHR) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0....

Core News & Articles

Truist Securities analyst Michael Lewis reiterates American Healthcares (NYSE:AHR) with a Buy and raises the price target fr...

Core News & Articles

JMP Securities analyst Aaron Hecht reiterates American Healthcares (NYSE:AHR) with a Market Outperform and maintains $16 pri...

Core News & Articles

American Healthcares (NYSE:AHR) reported quarterly earnings of $0.30 per share which met the analyst consensus estimate. This i...

Core News & Articles

Truist Securities analyst Michael Lewis maintains American Healthcares (NYSE:AHR) with a Buy and lowers the price target fro...

Core News & Articles

Truist Securities analyst Michael Lewis reiterates American Healthcares (NYSE:AHR) with a Buy and maintains $17 price target.

Core News & Articles

JMP Securities analyst Aaron Hecht reiterates American Healthcares (NYSE:AHR) with a Market Outperform and maintains $16 pri...

Core News & Articles

Key Highlights:Reported GAAP net loss attributable to stockholders of $(0.42) and $(1.08) per basic and diluted share for the t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION